GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $489,000 | -23.7% | 11,231 | -23.7% | 0.05% | +160.0% |
Q1 2022 | $641,000 | -1.7% | 14,714 | -0.5% | 0.02% | +5.3% |
Q4 2021 | $652,000 | -69.2% | 14,786 | -73.4% | 0.02% | -38.7% |
Q3 2021 | $2,120,000 | -4.2% | 55,496 | -0.2% | 0.03% | -31.1% |
Q2 2021 | $2,214,000 | +12.8% | 55,596 | +1.1% | 0.04% | -4.3% |
Q1 2021 | $1,963,000 | -2.6% | 55,001 | +0.5% | 0.05% | -9.6% |
Q4 2020 | $2,015,000 | +0.0% | 54,747 | +2.3% | 0.05% | -16.1% |
Q3 2020 | $2,014,000 | -7.7% | 53,520 | 0.0% | 0.06% | -8.8% |
Q2 2020 | $2,183,000 | -29.9% | 53,520 | -34.9% | 0.07% | +23.6% |
Q1 2020 | $3,114,000 | +61.3% | 82,188 | +100.0% | 0.06% | +7.8% |
Q4 2019 | $1,931,000 | +10.1% | 41,094 | 0.0% | 0.05% | +4.1% |
Q3 2019 | $1,754,000 | +27.8% | 41,094 | +19.9% | 0.05% | +25.6% |
Q2 2019 | $1,372,000 | -4.2% | 34,274 | 0.0% | 0.04% | 0.0% |
Q1 2019 | $1,432,000 | +9.9% | 34,274 | +0.5% | 0.04% | +5.4% |
Q4 2018 | $1,303,000 | -3.5% | 34,108 | +1.5% | 0.04% | +8.8% |
Q3 2018 | $1,350,000 | – | 33,600 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |